Table 1 Demographic, pre-operative baseline characteristics, and surgical data by treatment group

Eyes analyzed (n):

66

67

Right: Left

32 (48.5 %): 34 (51.5 %)

34 (50.7 %): 33 (49.3 %)

-

Female: Male

37 (56.1 %): 29 (43.9 %)

40 (59.7 %): 27 (40.3 %)

-

Age (years)

69.92 ± 11.73 (51 to 88)

67.3 ± 11.99 (40 to 85)

0.168

UDVA (decimal)

0.28 ± 0.23 (0.01 to 0.80)

0.30 ± 0.24 (0.01 to 0.80)

0.821

CDVA (decimal)

0.68 ± 0.27 (0.01 to 1.00)

0.69 ± 0.22 (0.01 to 1.00)

0.78

Sphere (D)

−1.96 ± 4.72 (-15.75 to +9.125)

−1.62 ± 4.33 (-14.25 to +7.125)

0.65

Cylinder (D)

−1.07 ± 0.88 (-4.00 to 0.00)

−0.96 ± 0.8 (-5.00 to 0.00)

0.781

Flat keratometry (D)

42.99 ± 1.29 (39.29 to 45.18)

43.32 ± 1.26 (41.25 to 46.59)

0.821

Steep keratometry (D)

44.07 ± 1.25 (41.24 to 46.83)

44.16 ± 1.54 (41.82 to 48.54)

0.982

IOP (mmHg)

15.48 ± 3.78 (8 to 28)

14.95 ± 2.96 (9 to 22)

0.691

Target Sphere (D)

−0.17 ± 0.51 (-2.50 to 0.00)

−0.05 ± 0.25 (-1.50 to 0.00)

0.075

Target Cylinder (D)

0.18 ± 0.24 (0.00 to 0.50)

0.18 ± 0.24 (0.00 to 0.50)

0.923

Axial Length (mm)

24.72 ± 2.72 (20.20 to 36.30)

24.09 ± 1.75 (21.42 to 30.00)

0.834

LOCS classification

2.59 ± 0.94 (1 to 4)

2.37 ± 1.18 (1 to 4)

0.753

Phacoemulsification time (s)

160 ± 58 (99 to 225)

77 ± 39 (25 to 145)

0.015

Cumulative dissipated energy (J)

5.3 ± 2.8 (1.9 to 7.5)

2.4 ± 2.2 (0.9-5.4)

0.024

IOL Sphere power implanted (D)

18.95 ± 6.22 (2.00 to 36.00)

20.10 ± 5.01 (4.00 to 28.00)

0.643

# of toric IOL implanted

27/66

25/67

-

IOL Cylinder Power implanted (D)

1.87 ± 0.70 (0.00 to 3.80)

1.38 ± 0.72 (0.00 to 3.00)

0.235